Enzyme expression profiles suggest the novel tumor-activated fluoropyrimidine carbamate capecitabine (Xeloda) might be effective against papillary thyroid cancers of children and young adults

By Patel Aneeta   Pluim Thomas   Helms Amy   Bauer Andrew   Tuttle R.   Francis Gary  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 5, 2004-05 ,pp. : 409-414

Springer Publishing Company

Access to resources Recommend Favorite

Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis

By Inokuchi Mikito   Uetake Hiroyuki   Shirota Yoshinori   Yamada Hiroyuki   Tajima Masayuki   Sugihara Kenichi  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 5, 2004-05 ,pp. : 391-396

Springer Publishing Company

Access to resources Recommend Favorite

5-Fluorouracil and cisplatin in the treatment of advanced oral cancer

By Andreadis C.   Vahtsevanos K.   Sidiras T.   Thomaidis I.   Antoniadis K.   Mouratidou D.  

Oral Oncology, Vol. 39, Iss. 4, 2003-06 ,pp. : 380-385

Elsevier

Access to resources Recommend Favorite

Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway

By Ichikawa Wataru  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 145-155

Springer Publishing Company

Access to resources Recommend Favorite

Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells

By                      

International Journal of Oncology, Vol. 41, Iss. 3, 2012-01 ,pp. : 1148-1156

Spandidos Publications

Access to resources Recommend Favorite